Neurocognitive, symptom, and health-related quality of life outcomes of a randomized trial of bevacizumab for newly diagnosed glioblastoma (NRG/RTOG 0825) Article

fiu authors

publication date

  • July 1, 2021

keywords

  • Neurosciences & Neurology
  • neurocognitive function

start page

  • 1125

end page

  • 1138